(Q36951047)

17 August 2017

1 reference

title

Accelerated atherosclerosis in rheumatoid arthritis (English)

1 reference

17 August 2017

1 reference

0 references

15

Yehuda Shoenfeld

1 reference

17 August 2017

1

Zoltán Szekanecz

1 reference

17 August 2017

11

Gabriella Szücs

1 reference

17 August 2017

14

Gyula Szegedi

1 reference

17 August 2017

György Kerekes

2

1 reference

17 August 2017

Henriett Dér

3

1 reference

17 August 2017

Zsuzsa Sándor

4

1 reference

17 August 2017

Zoltán Szabó

5

1 reference

17 August 2017

Anikó Végvári

6

1 reference

17 August 2017

Enikö Simkovics

7

1 reference

17 August 2017

Lilla Soós

8

1 reference

17 August 2017

Agnes Szentpétery

9

1 reference

17 August 2017

Timea Besenyei

10

1 reference

17 August 2017

Sándor Szántó

12

1 reference

17 August 2017

László Tamási

13

1 reference

17 August 2017

Pál Soltész

16

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Annals of the New York Academy of Sciences

17 August 2017

published in

1 reference

17 August 2017

volume

1108

1 reference

17 August 2017

page(s)

349-358

1 reference

Accelerated atherosclerosis in autoimmune rheumatic diseases

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Mechanisms of disease: atherosclerosis in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Cardiovascular disease in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Cardiovascular risk factors in women with and without rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

A long and winding road: defining the biological role and clinical importance of paraoxonases

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Prevention of the platelet alpha-granule release reaction by membrane-active drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Statins: immunomodulators for autoimmune rheumatic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.036

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1422.036

1 reference

17 August 2017

1 reference